Puma Biotechnology
Puma Biotechnology is a California-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of HER2+ breast cancer patients.
Business Model:
Revenue: $217.7M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Puma Biotechnology Information
Geographic Data
Address: 10880 Wilshire Blvd.
City: Los Angeles
State: CA
Zip: 90024
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$10M
Raised Total:$395M
Social
Metrics
4,229,397Website Global Rank
2,776Website Monthly Traffic
Twitter Followers
Description
Puma Biotechnology is a California-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of HER2+ breast cancer patients.
Contact Phone:
+14242486500
Contact Email:
Puma Biotechnology went public on 4/20/2012 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
4/20/2012
IPO Valuation:
$441M
Ticker Symbol:
PBYI
IPO Price:
$16/share
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2021 | Post-IPO Debt | $100M |
Athyrium Capital Management |
10/2012 | IPO | $120M | 10/2011 | Equity | $70M | 11/2011 | Equity | $5M | 1/2015 | Post-IPO Equity | $218M | 10/2011 | Post-IPO Equity | 8 | $55M |
OrbiMed Sahsen Ventures H&a;Q Healthcare Investors T. Rowe Price Adage Capital Management Bain Capital Public Equity Jennison Associates Tekla Capital Management OrbiMed Sahsen Ventures H&a;Q Healthcare Investors T. Rowe Price Adage Capital Management |
11/2017 | Post-IPO Equity | 2 | $100M |
Silicon Valley Bank Oxford Finance LLC Silicon Valley Bank Oxford Finance LLC |
10/2016 | Post-IPO Equity | $172M | 7/2021 | Post-IPO Debt | 2 | $125M |
Armentum Partners Athyrium Capital Management LP Athyrium Capital Management LP Armentum Partners Athyrium Capital Management LP Athyrium Capital Management LP |
3/2022 | Post-IPO Equity | 2 | $10M |
Alan H. Auerbach Athyrium Capital Management LP Alan H. Auerbach Athyrium Capital Management LP |
2/2014 | Post-IPO Equity | $129.3M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
